The Latest Cardiac and Vascular News
VANCOUVER, Sept. 18, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ :NVCN )(TSX :NVCN ), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Company has filed articles of amendment, effective […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the company has randomized its first patient in the CARILLON Pivotal Trial. The CARILLON Trial is evaluating the Carillon® Mitral Contour System®for the treatment of functional […]
EDMONTON, Alberta–(BUSINESS WIRE)–IMBiotechnologies Ltd. today announced that an oral presentation regarding the use of its lead product, Occlusin® 500 Embolization Microspheres (Occlusin 500), in benign prostatic hypertrophy (BPH) patients will be presented at the 2018 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting. Dr. Richard Owen, lead investigator […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Hong Kong has been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS). The Hong […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2018 Healthcare Conference as follows: Date: Tuesday, October 2, 2018 Time: 4:00pm EDT Location: Sofitel New York, New […]
FRAMINGHAM, Mass.–(BUSINESS WIRE)–Boston Heart Diagnostics, one of the leading disease management laboratories in the United States, is pleased to announce the company’s newly-appointed scientific advisory board. Boston Heart Diagnostics’ 2018 Scientific Advisory Board is comprised of recognized experts in their respective medical fields. Boston Heart Diagnostics’ Scientific Advisory Board includes: […]
OAKLAND, Calif.–(BUSINESS WIRE)–LUMEDX Corporation, a provider of wholly integrated cardiovascular data intelligence and imaging solutions, announced today that it is working with Duke Health to implement a comprehensive cardiovascular information system (CVIS) for Duke’s non-invasive cardiac labs. The implementation marks the third phase of a larger Duke-LUMEDX CVIS project, which […]
RESEARCH TRIANGLE PARK, N.C. & TORONTO–(BUSINESS WIRE)–Analytics 4 Life, a digital health company dedicated to improving existing diagnostic pathways, today announced that clinical data will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. Dr. Thomas Stuckey, a primary investigator on the Company’s Coronary Artery Disease Learning and […]
LAVAL, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today provided a clinical and market update. Jan D’Alvise, president […]
WESTMINSTER, Colo., Sept. 18, 2018 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that it has submitted a Special Protocol Assessment (SPA) request to the U.S. Food and Drug Administration (FDA). The request is part of the […]
